Spots Global Cancer Trial Database for Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Official Title: Stereotactic Body Radiotherapy in Addition to Standard of Care Treatment in Patients With Rare Oligometastatic Cancers (OligoRARE): a Randomized, Phase 3, Open-label Trial
Study ID: NCT04498767
Study Description
Brief Summary: This is a randomized open-label multicentre Phase III superiority study of the effect of adding SBRT to the standard of care treatment on overall survival in patients with rare oligometastatic cancers. Patients will be randomized in a 1:1 ratio between current standard of care treatment vs. standard of care treatment + SBRT to all sites of known metastatic disease. The primary objective of this trial is to assess if the addition of stereotactic body radiotherapy (SBRT) to standard of care treatment improves overall survival (OS) as compared to standard of care treatment alone in patients with rare oligometastatic cancers.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Institut Jules Bordet, Anderlecht, , Belgium
Universitair Ziekenhuis Gent, Gent, , Belgium
Gasthuiszusters Antwerpen - Sint-Augustinus, Wilrijk, , Belgium
Centre Oscar Lambret, Lille, , France
Gustave Roussy, Villejuif, , France
Universitaets Krankenhaus Eppendorf - Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center, Hamburg, Martinistrasse 52, Germany
Istituto Europeo di Oncologia, Milano, , Italy
Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, , Poland
Inselspital, Bern, , Switzerland
UniversitaetsSpital Zurich, Zurich, , Switzerland
University Hospitals Birmingham NHS Foundation Trust (UHB) - UHB-Queen Elisabeth Medical Centre, Birmingham, , United Kingdom
Royal Marsden Hospital - site: Chelsea, London, London, , United Kingdom
Contact Details
Name: Matthias Guckenberger
Affiliation: University of Zurich
Role: PRINCIPAL_INVESTIGATOR
Name: Piet Ost
Affiliation: Gasthuiszusters Antwerpen - Sint-Augustinus
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
